The Serum Level of Midkine, a Heparin-Binding Growth Factor, as a Tumor Marker

Biomedical Research - Japan
doi 10.2220/biomedres.18.375
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Biomedical Research Press

Related search

Preoperative Serum Placenta Growth Factor Level as a New Marker for Stage II or III Colorectal Cancer Patients

Turkish Journal of Gastroenterology
Gastroenterology
2012English

Midkine, a Heparin-Binding Cytokine With Multiple Roles in Development, Repair and Diseases

Proceedings of the Japan Academy Series B: Physical and Biological Sciences
MultidisciplinaryBiological SciencesMedicineAgriculturalAstronomyPhysics
2010English

Serum Level of SHAP as a Disease Marker: A Comparison With Hyaluronan

Trends in Glycoscience and Glycotechnology
BiochemistryOrganic Chemistry
2010English

Appearance of Heparin-Binding EGF-like Growth Factor in Wound Fluid as a Response to Injury.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1993English

Suppression of the Biological Activities of the Epidermal Growth Factor (EGF)-like Domain by the Heparin-Binding Domain of Heparin-Binding EGF-like Growth Factor

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2004English

Heparin-Dependent Binding and Autophosphorylation of Epidermal Growth Factor (EGF) Receptor by Heparin-Binding EGF-like Growth Factor but Not by EGF.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1994English

Analysis of Mice Lacking the Heparin-Binding Splice Isoform of Platelet-Derived Growth Factor A

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2013English

Serum Galectin-3 Level as a Marker of Thrombogenicity in Atrial Fibrillation

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2017English

Membrane Type 1-Matrix Metalloproteinase Cleaves Off the NH2-Terminal Portion of Heparin-Binding Epidermal Growth Factor and Converts It Into a Heparin-Independent Growth Factor

Cancer Research
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy